Coastlands Capital LP reports $8,689 Adial Pharmaceuticals common share purchase
ADIL•Coastlands Capital increases Adial Pharmaceuticals stake
- Coastlands Capital, a 10% owner of Adial Pharmaceuticals, increased its stake through open-market purchases.
- Holdings rose to 388,308 shares, up 3,233 shares.
- Shares were bought at prices ranging from $2.65 to $2.75.
Related News
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma
JSPR•
Roku CFO and COO Dan Jedda disposes of 7,000 common shares worth $993,300
ROKU•
